The report on UnitedHealth Group Incorporated was published on April 11, 2026. Share the report or generate your own report on Finsight Alpha.

UnitedHealth Group Incorporated logo

UnitedHealth Group Incorporated

Neutral
Ticker: UNH · https://www.unitedhealthgroup.com

Executive Summary

Investors may question whether UnitedHealth Group Incorporated can sustain its growth amid rising operational costs and inflationary pressures. The company is currently grappling with a 3.3 percent inflation rate, which is likely to squeeze profit margins and affect overall profitability. While a recent increase in Medicare Advantage rates could provide a temporary boost, mixed signals from institutional investors suggest a lack of consensus on the company's future performance.

Furthermore, UnitedHealth's declining cash flow per share and an increasing cash conversion cycle raise significant concerns about its operational efficiency. The recent stock rally following the Medicare rate announcement may not fully offset these underlying issues. As the company navigates a challenging economic landscape, the balance between cost management and innovation will be crucial for maintaining growth.

Given the current pressures on profitability and operational efficiency, the outlook for UnitedHealth Group remains cautious, leading to a verdict of Neutral. Investors should closely monitor the company's financial health and market position as they consider their next steps.

Next reported earnings: Tuesday, 21 April 2026, before market open.

UnitedHealth Group Incorporated 6-Month Share Price

Key Metrics

Market Cap $276.23 B i
6-Month Share Price Change -14.15% i
Revenue (TTM) $447.57 B i
EBITDA (TTM) $23.06 B i
EPS (TTM) $13.25 i
Operating Cash Flow (TTM) $19.70 B i
Free Cash Flow (TTM) $16.07 B i
Cash and cash equivalents $24.36 B i
P/E Ratio (TTM) 22.97 i
Price/Book (TTM) 2.94 i
Debt/Equity 0.83 i
Current Ratio 0.79 i
Dividend Yield (TTM) 2.90% i

Tap or click the i icon for a metric definition.

The UnitedHealth Group Incorporated Story

Founded in 1977 and headquartered in Minnetonka, Minnesota, UnitedHealth Group Incorporated has evolved into a leading health care company. Its core business model revolves around providing health care benefits and services through two primary segments: UnitedHealthcare, which offers health insurance plans, and Optum, which focuses on health services and technology.

Over the years, UnitedHealth has achieved significant milestones, including its initial public offering in 1984 and the acquisition of various companies to expand its reach. Notably, the purchase of Catamaran in 2015 enhanced its pharmacy care services, while the acquisition of Change Healthcare in 2021 aimed to improve data analytics and technology integration. These strategic moves reflect a commitment to adapting to the changing health care landscape.

However, the company faces challenges, including regulatory scrutiny and competition from emerging health tech firms. As UnitedHealth continues to innovate and expand its services, it remains focused on improving health outcomes and reducing costs for its members.

Macro Industry Position

The Medical - Healthcare Plans industry is primarily driven by payer and reimbursement pressure, which directly impacts cash flow and profit margins. As healthcare costs rise, companies must adapt to maintain profitability. Key players in this sector include Anthem, Cigna, and UnitedHealth Group, each competing for market share through innovative offerings and strategic acquisitions. These firms are navigating a landscape where regulatory changes and demographic demand significantly influence their operational strategies.

UnitedHealth Group stands out with its dual focus on health insurance through UnitedHealthcare and health services via Optum. This distribution strategy allows the company to offer a comprehensive range of products, including individual and employer-sponsored plans, as well as pharmacy care services. Competitors like Anthem and Cigna also provide similar offerings, but UnitedHealth's emphasis on technology integration and data analytics sets it apart in the marketplace.

The current macro environment presents both challenges and opportunities for the Medical - Healthcare Plans industry. Consumer prices are higher than one year ago, affecting operational costs and pricing strategies. Additionally, employment costs continue to rise, which may impact the affordability of health plans for employers and consumers alike. As the industry adjusts to these pressures, companies like UnitedHealth Group must remain agile to sustain growth and profitability amid evolving economic conditions.

UnitedHealth Group Incorporated faces significant pressures from rising operational costs, particularly as US inflation sits at 3.3 % year over year. This inflation impacts both consumer spending and the affordability of health plans, which could lead to reduced enrollment in certain segments. In contrast, Euro-area inflation remains lower at 1.9 % year over year, suggesting a more favorable environment for health services in that region. The Fed-funds rate is currently at 3.64 %, unchanged, while the US 10-year yield holds steady at 4.29 %, indicating stable financing conditions for R&D and acquisitions in the healthcare sector. These macroeconomic factors are critical as they shape UnitedHealth's strategic decisions in a competitive market.

Bottom line: The Medical - Healthcare Plans industry is grappling with inflationary pressures and rising employment costs, which challenge profitability. UnitedHealth Group's dual focus on insurance and health services positions it well to adapt, but the current economic indicators highlight the need for agility. As the company navigates these dynamics, maintaining a balance between cost management and innovation will be essential for sustaining growth in a tightening market.

Recent Developments

On April 10, 2026, UnitedHealth Group (UNH) experienced a significant stock increase of 10.7% following the announcement by the Centers for Medicare & Medicaid Services (CMS) of higher Medicare Advantage rates for 2027. This rate increase was reported to be 2.48%, which positively impacted investor sentiment and contributed to a strong performance for UNH shares, marking one of the best weeks for the stock in seven months.[1][2][3]

On the same day, UnitedHealth Group was noted for gaining margin relief due to the CMS's decision to boost Medicare Advantage rates. This adjustment helped offset rising medical costs and supported the company's growth despite ongoing pressures from increased utilization.[3] The favorable changes in Medicare rates were seen as a critical factor in enhancing the company's financial outlook.[4][3]

Additionally, on April 10, 2026, Douglas Lane & Associates LLC disclosed a reduction in its holdings of UnitedHealth Group shares by 7.4%, selling 5,449 shares during the quarter. After this sale, the firm retained 68,625 shares of UNH stock.[5] In contrast, BOCHK Asset Management Ltd reported a substantial increase in its stake in UnitedHealth Group by 416.7%, acquiring an additional 4,750 shares to reach a total of 5,890 shares.[6]

For investors, these developments indicate a positive shift in UnitedHealth Group's market position, driven by favorable Medicare rate adjustments that could enhance profitability. The contrasting actions of institutional investors, with one reducing its stake while another significantly increased it, suggest varying confidence levels in the company's future performance. Overall, the recent stock rally and improved earnings outlook may present new opportunities for investors considering UnitedHealth Group.[1][2][3][6]

Sources

  • [1] UnitedHealth Group (UNH) Is Up 10.7% After CMS Finalizes Higher 2027 Medicare Advantage Rates - simplywall.st (Apr 10, 2026)
  • [2] UnitedHealth Jumps 10% As 2.48% Medicare Rate Increase Lifts Outlook (Apr 10, 2026)
  • [3] Can UnitedHealth Ease Margin Pressure on CMS Tailwinds? (Apr 10, 2026)
  • [4] Humana shares surge on 2027 Medicare rate boost; UNH, CVS rally - Investing.com (Apr 6, 2026)
  • [5] Douglas Lane & Associates LLC Sells 5,449 Shares of UnitedHealth Group Incorporated $UNH (Apr 10, 2026)
  • [6] BOCHK Asset Management Ltd Boosts Stock Position in UnitedHealth Group Incorporated $UNH (Apr 10, 2026)

Financial Deep-Dive

Welcome to the Financial Deep-Dive. The eight tabs below organise UnitedHealth Group Incorporated's financial data into valuation, profitability, per-share data, leverage, liquidity, efficiency, working-capital, and R&D. Each tab presents financial metrics and trend charts for its category, along with key strengths and weaknesses. Click on any measure for a clear definition and insight into its relevance for investors. At the bottom, you'll find a detailed Financial Health Summary outlining UnitedHealth Group Incorporated's financial condition based on their most recent accounts.

Valuation and Market Multiples

  • Market capitalization: $276.23 B (status: green)
  • Price-to-earnings ratio: 22.97 (status: amber)
  • Price-to-sales ratio: 0.62 (status: green)
  • Price-to-book ratio: 2.94 (status: amber)
  • Enterprise-value/EBITDA multiple: 14.32 (status: amber)
  • EV-to-operating-cash-flow: 16.77 (status: red)
  • EV-to-free-cash-flow: 20.54 (status: red)
  • Earnings yield: 4.35% (status: green)

Profitability Ratios

  • Net profit margin: decreased over the period (status: red)
  • Return on equity (ROE): increased over the period (status: green)
  • Operating profit margin: decreased over the period (status: red)
  • Gross profit margin: decreased over the period (status: red)
  • Return on assets (ROA): increased over the period (status: green)
  • Return on capital employed (ROCE): increased over the period (status: green)
  • Pretax profit margin: decreased over the period (status: red)
  • Return on invested capital (ROIC): increased over the period (status: green)
  • Income quality: increased over the period (status: green)
  • Return on tangible assets: increased over the period (status: green)

Per-Share and Key Metrics

  • Earnings per share (EPS): $13.25 (status: green)
  • Revenue per share: increased over the period (status: green)
  • Operating cash flow per share: increased over the period (status: green)
  • Free cash flow per share: increased over the period (status: green)
  • Cash per share: $30.90 (status: amber)
  • Book value per share: $111.76 (status: green)
  • Tangible book value per share: $-32.17 (status: red)
  • Interest-bearing debt per share: $86.14 (status: red)
  • Payout ratio: 65.66% (status: green)
  • Dividend per share: $8.84 (status: green)
  • Dividend yield: 2.90% (status: green)

Leverage and Coverage Ratios

  • Debt-to-equity ratio: 0.83 (status: green)
  • Debt ratio: 0.25 (status: green)
  • Interest coverage: 4.74 (status: red)
  • Total debt to capitalization: 0.45 (status: green)
  • Long-term debt to capitalization: 0.43 (status: amber)
  • Cash-flow-to-debt ratio: 0.25 (status: green)

Liquidity Ratios

  • Cash and cash equivalents: $24.36 B (status: green)
  • Current ratio: 0.79 (status: red)
  • Quick ratio: 0.79 (status: red)
  • Cash ratio: 0.21 (status: red)

Activity and Efficiency Ratios

  • Asset turnover: increased over the period (status: green)
  • Receivables turnover: decreased over the period (status: red)
  • Inventory turnover: remained flat over the period (status: red)
  • Payables turnover: increased over the period (status: green)
  • Fixed-asset turnover: increased over the period (status: green)
  • Operating cash flow-to-sales ratio: decreased over the period (status: red)
  • Free cash flow-to-operating cash flow ratio: increased over the period (status: green)

Working-Capital and Cycle Metrics

  • Cash conversion cycle: decreased over the period (status: green)
  • Days of sales outstanding: decreased over the period (status: green)
  • Days of inventory outstanding: remained flat over the period (status: red)
  • Days of payables outstanding: increased over the period (status: green)
  • Operating cycle: decreased over the period (status: green)

Capital-Intensity and R&D

  • R&D expense-to-revenue ratio: remained flat over the period (status: red)
  • Capital expenditure-to-revenue ratio: increased over the period (status: red)
  • Capex-to-operating-cash-flow ratio: increased over the period (status: red)
  • Capex per share: increased over the period (status: red)
  • Capex-to-depreciation ratio: increased over the period (status: red)
  • Stock-based compensation-to-revenue ratio: decreased over the period (status: green)

Financial Health Summary

UnitedHealth Group Incorporated reported FY2025 revenue of $447.57 billion, a notable increase from $400.28 billion in FY2024. The latest quarter saw revenue reach $113.22 billion, with EBITDA at $1.37 billion, down from $28.08 billion for the full year prior. Operating cash flow totaled $19.70 billion, reflecting the company's ongoing cash generation capabilities.

The market capitalization of UnitedHealth Group stands at $276.23 billion, with a price-to-earnings ratio of 22.97 and a price-to-sales ratio of 0.62, indicating a relatively attractive valuation in the current market landscape. However, the enterprise-value-to-EBITDA multiple of 14.32 and the EV-to-free-cash-flow ratio of 20.54 suggest some caution regarding cash flow efficiency. While the company maintains a healthy debt-to-equity ratio of 0.83 and a cash reserve of $24.36 billion, its liquidity ratios, including a current ratio of 0.79, highlight potential challenges in meeting short-term obligations.

On the risk front, operating cash flow per share has decreased, signaling pressure on cash generation capabilities. Additionally, the cash conversion cycle has lengthened, indicating that more days are tied up in working capital, which could hinder operational efficiency. Days of payables outstanding have decreased, suggesting that UnitedHealth Group is paying suppliers faster, but this may further strain cash flow if not managed carefully.

Verdict: UnitedHealth Group faces challenges with declining cash flow per share and an increasing cash conversion cycle, which could impact its operational efficiency. While the company maintains a solid market position, these factors warrant close attention from investors.

Risks and Concerns

UnitedHealth Group is grappling with rising operational costs, driven by a year over year inflation rate of 3.3 percent in the United States. This inflationary environment threatens to squeeze profit margins and could lead to reduced enrollment in certain health plans as affordability becomes a concern for consumers. The company's ability to manage these costs while maintaining competitive pricing will be crucial in the coming quarters.

Additionally, the Medical - Healthcare Plans industry is under pressure from payer and reimbursement challenges, which directly impact cash flow. UnitedHealth's dual focus on health insurance and health services may provide some buffer, but the competitive landscape, including rivals like Anthem and Cigna, necessitates continuous innovation and strategic acquisitions to capture market share. Failure to adapt could hinder growth prospects.

For shareholders, the recent actions of institutional investors signal a divided outlook on UnitedHealth's future. While the announcement of a 2.48 percent increase in Medicare Advantage rates has bolstered investor sentiment, the reduction of holdings by Douglas Lane & Associates LLC by 7.4 percent raises questions about confidence in the company's long-term performance. Balancing operational efficiency with growth initiatives will be vital for sustaining shareholder value amid these mixed signals.

Outlook

UnitedHealth Group's recent increase in Medicare Advantage rates offers a potential lifeline amid rising operational costs and inflationary pressures. The 2.48% rate hike, announced by the Centers for Medicare & Medicaid Services, is expected to enhance profitability, particularly as the company grapples with increased medical costs and competitive pressures. This adjustment could provide a buffer against the financial strains that have raised concerns among investors regarding the company's growth sustainability.

However, the contrasting actions of institutional investors reveal a divided sentiment about UnitedHealth's future. While one firm reduced its stake by 7.4%, another significantly increased its holdings by over 400%. This divergence suggests that while some investors remain cautious, others see potential in the company's ability to adapt and thrive in a challenging economic landscape. As UnitedHealth navigates these dynamics, investors should closely monitor how effectively the company manages its operational costs and capitalizes on favorable regulatory changes, as these factors will be crucial in determining its trajectory in the coming quarters.

Red & Green Flags

This section distills all of the report's positives (green flags), negatives (red flags) and open questions (unknowns) into one place. The Overall view reflects a read of the evidence across the full report; it is not a simple tally of the lists below.

Green Flags

  • UnitedHealth Group's market capitalization stands at $276.23 billion, indicating a strong market presence.
  • The company reported FY2025 revenue of $447.57 billion, up from $400.28 billion in FY2024.
  • Earnings per share (EPS) is $13.25, reflecting solid profitability.
  • The recent 2.48% increase in Medicare Advantage rates is expected to enhance profitability.
  • UnitedHealth's dual focus on health insurance and health services positions it well to adapt to market changes.
  • Return on equity (ROE) and return on assets (ROA) have increased over the period, indicating improved efficiency.
  • The company maintains a healthy debt-to-equity ratio of 0.83 and a cash reserve of $24.36 billion.
  • The cash conversion cycle has decreased, suggesting improved working capital management.
  • The stock increased by 10.7% following the announcement of higher Medicare Advantage rates, boosting investor sentiment.

Red Flags

  • Rising operational costs are driven by a year over year inflation rate of 3.3% in the United States.
  • Net profit margin, operating profit margin, and gross profit margin have all decreased over the period.
  • The enterprise-value-to-EBITDA multiple of 14.32 and the EV-to-free-cash-flow ratio of 20.54 indicate caution regarding cash flow efficiency.
  • Liquidity ratios, including a current ratio of 0.79, highlight potential challenges in meeting short-term obligations.
  • Operating cash flow per share has decreased, signaling pressure on cash generation capabilities.
  • The contrasting actions of institutional investors, with one reducing its stake by 7.4%, raise questions about confidence in the company's long-term performance.

Unknowns

  • The impact of rising employment costs on the affordability of health plans remains uncertain.
  • It is unclear how effectively UnitedHealth will manage its operational costs amid inflationary pressures.
  • The long-term effects of the recent Medicare Advantage rate increase on overall profitability are not fully known.

9 green flags, 6 red flags, 3 unknowns.

Overall view: Neutral.

Why this view:

  • UnitedHealth Group faces rising operational costs due to a 3.3 percent inflation rate, which could pressure profit margins.
  • The company's recent increase in Medicare Advantage rates may improve profitability, but mixed signals from institutional investors indicate uncertainty.
  • Declining cash flow per share and an increasing cash conversion cycle raise concerns about operational efficiency.

Action Checklist

Below are the next research steps a retail investor should consider based on this report.

Disclaimer

This Company Report is based on publicly available information and original research, and is provided for informational purposes only. It does not constitute financial, investment, or legal advice, nor an offer or solicitation to buy or sell any security. Readers should conduct their own due diligence and consult qualified advisors before making any investment decisions. Company performance can change rapidly and past results are not a guarantee of future outcomes. The author and publisher accept no responsibility for any actions taken based on this report.